Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

AdaptHealth Narrows FY2025 Sales Guidance from $3.150B-$3.290B to $3.180B-$3.260B vs $3.252B Est

Author: Benzinga Newsdesk | August 05, 2025 06:06am

Financial Outlook

The Company is updating previous financial guidance for fiscal year 2025, as follows:

Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billion
Adjusted EBITDA of $642 million to $682 million, from $662 million to $702 million
Free cash flow of $170 million to $190 million, unchanged

Posted In: AHCO